Charles Cherington bought $24k of CMRA
owner at Comera Life Sciences Holdings, Inc.. 15,007 shares at an average of $1.58, traded Oct 20, 2022, filed Oct 24, 2022.
Score components
- +12Role10% owner
- 0Trade size$24k at market
- 0Relative to holdingsHoldings up 2.4%
- +8Price context83% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying3 buys in 90 days
- -5Track recordMedian 6-month excess return -62% over 3 past buys
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -8.6%, 3m -5.3%, 6m -47.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-22-021051, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 20, 2022 | POpen-market purchase Common Stock | +3,316 | $1.52 | $5,048 | 638,246 | Oct 24, 2022 |
| Oct 21, 2022 | POpen-market purchase Common Stock | +11,691 | $1.59 | $19k | 649,937 | Oct 24, 2022 |
Related signals
Other insiders at Comera Life Sciences Holdings, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 36Weak | CMRAbuy Comera Life Sciences Holdings, Inc. | Michael Gerard Campbell EVP & CFO | $708 10,000 shares | +40% | |
| 48Moderate | Comera Life Sciences Holdings, Inc. | Sirshendu Roopom Banerjee director | $25k 20,270 shares | +233% | |
| 48Moderate | Comera Life Sciences Holdings, Inc. | Kirsten Flowers director | $17k 13,513 shares | +156% | |
| 48Moderate | Comera Life Sciences Holdings, Inc. | Edward Aloysius Sullivan Jr. director | $14k 10,979 shares | +126% | |
| 44Moderate | Comera Life Sciences Holdings, Inc. | Barbara K Finck director | $8,310 6,756 shares | +42% | |
| 54Moderate | Comera Life Sciences Holdings, Inc. | Stuart A Randle director | $42k 33,783 shares | +389% | |
| 54Moderate | Comera Life Sciences Holdings, Inc. | James Sherblom director | $100k 81,081 shares | +22% | |
| 60Notable | Comera Life Sciences Holdings, Inc. | Charles Cherington owner | $914k 743,243 shares | +35% | |
| 51Moderate | Comera Life Sciences Holdings, Inc. | David Soane owner | $249k 202,701 shares | +6% | |
| 10Weak | CMRAbuy Comera Life Sciences Holdings, Inc. | David Soane owner | $4,148 3,000 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.